Regarding the distribution of mutations according to tumor grades and subtypes, all mutations were present in most subtypes and grades analyzed, except for SMO L412F which was absent in grade II patients, which could be partly due to the reduced size of our cohort. This evidence concerns the gene SMO and neoplasm.